Little is known about the role of alcohol and smoking in GI cancer survival compared to GI cancer development. We systematically reviewed the evidence for a role of smoking and alcohol in prognosis among GI cancer patients and inform whether smoking or alcohol cessation interventions or guidelines for GI cancer patients are likely to improve prognosis. A total of 84 relevant studies were identified. Continued smokers, particularly heavy smokers, had worse prognosis than never smokers in most GI cancers. However, more evidence is needed to establish the likely impact of smoking cessation interventions amongst GI cancer patients. Heavy alcohol drinkers had worse prognosis in oesophageal squamous cell carcinoma and hepatocellular carcinoma patients. Light alcohol consumption was not associated with worse prognosis from any GI cancer, though further studies are needed. UK guidelines for the general population recommending under 14 units (∼7 drinks) per week may be sufficient for GI cancer patients, until further evidence is available.
|Journal||Best Practice & Research: Clinical Gastroenterology|
|Early online date||23 Sep 2017|
|Publication status||Early online date - 23 Sep 2017|
FingerprintDive into the research topics of 'Do smoking and alcohol behaviours influence GI cancer survival?'. Together they form a unique fingerprint.
Epidemiological risk factors, related biomarkers and oesophageal adenocarcinoma survivalAuthor: McCain, S., Jul 2020
Supervisor: Coleman, H. (Supervisor) & Turkington, R. (Supervisor)
Student thesis: Doctoral Thesis › Doctor of PhilosophyFile